Home > News > Latest News

Latest News



 

Person wearing gloves and labelling tubes in a laboratory
T cells face off against variants to boost COVID-19 immunity
Thu, 12 Aug 2021 - 12:00

With the fight against COVID-19 beset with concerns around the efficacy of vaccines in the face of a mutating virus, University of Cape Town virologists have shown that the body’s T cells maintain 85% of their capacity to detect variants, continuing to mount a substantial defence to prevent severe illness, hospitalisation and death.

An icon of a medicine capsule on a two-tone blue background
HIV infection may be driving drug resistance in tuberculosis
Thu, 12 Aug 2021 - 09:00

Results published today in The Lancet Microbe detail analysis of 10 years’ health data, showing a relationship between HIV infection and acquisition of rifampicin resistance by tuberculosis. Rifampicin is an important first-line anti-tuberculosis medication.

The storm after the calm: the alpha, beta and gamma variants of SARS-CoV-2 are converging on similar adaptive endpoints
Mon, 02 Aug 2021 - 09:15

Ongoing adaptive evolutionary convergence of the alpha, beta and gamma variants could lead to additional variants displaying any combination of increased transmissibility, altered virulence and/or increased capacity to escape population immunity.

People with diabetes at risk of severe COVID-19, study confirms
Tue, 20 Jul 2021 - 09:00

A recent study from the University of Cape Town (UCT) confirmed that people living with diabetes (PLWD) are at an increased risk of severe COVID‑19 (hospitalisation and mortality). The findings were published in the journal Diabetes Research and Clinical Practice.

Investigating the dynamic inflammatory profile of tuberculosis patients with and without HIV-1 co-infection
Mon, 24 May 2021 - 08:30

Increased IL-17A network connectivity serves as an indicator of elevated systemic inflammation and immune activation induced by advanced HIV infection, and predicts mortality in patients with HIV-tuberculosis co-infection.

Fire affecting the Rondebosch campus of the University of Cape Town (UCT)
Mon, 19 Apr 2021 - 12:00

No classes, tutorials, laboratory work or tests will take place on Monday, 19 April or Tuesday, 20 April. For safety reasons, campus will be locked down and no one, other than emergency services, will be allowed access.

CIDRI-Africa enrolls first patient in the MESA-TB study
Wed, 14 Apr 2021 - 11:45

The phase 2 study will evaluate the safety and immunogenicity of the M72/AS01E TB vaccine in people living with HIV.

A red alarm clock on grass
“The clock is ticking”: engaging youth on TB developments in the time of COVID-19
Fri, 26 Mar 2021 - 09:30

CIDRI-Africa in collaboration with City Health, WITS RHI, MSF, TB HIV Care, SWEAT and the Centre of Science and Technology hosted 130 school learners in Khayelitsha for World TB Day 2021.

Linda Boloko on the left and Graeme Meintjes on the right, dressed in full PPE
Linda Boloko awarded Professor Bongani Mayosi Netcare Clinical Scholarship
Mon, 08 Mar 2021 - 08:30

Dr Linda Boloko has been awarded the Professor Bongani Mayosi Netcare Clinical Scholarship for 2021. Linda will conduct his PhD research within CIDRI-Africa.

SA launches COVID-19 vaccination drive
Thu, 25 Feb 2021 - 12:15

South Africa’s vaccination drive began on Wednesday, 17 February 2021, at the Khayelitsha Hospital, with President Cyril Ramaphosa, Minister of Health Dr Zweli Mkhize and various frontline healthcare workers among the first to receive the Johnson & Johnson (J&J) vaccine. 

CIDRI-Africa hosts Vaccine Literacy Training Workshop in Khayelitsha
Thu, 18 Feb 2021 - 10:30

The workshop covered: an introduction to vaccines, the difference between vaccination and immunisation, SARS-CoV-2 vaccine development and research, and myths about vaccines.

Professor Keertan Dheda joins CIDRI-Africa
Mon, 08 Feb 2021 - 10:30

Keertan is Head of the Division of Pulmonology in the Faculty of Health Sciences and leads the Centre for Lung Infection and Immunity, which is a UCT accredited centre with its clinical profiling facilities based at the University of Cape Town Lung Institute. He joins the Centre as a Contributing Investigator.

Pages

TOP